Schedule a consultation today Dr
On the other hand, a Japanese single-center, open-label trial compared sitagliptin at suboptimal dosage with glimepiride in a cohort of 20 diabetic patients with ultrasound evidence of fatty liver: after 24 weeks of treatment, in the sitagliptin group but not in the glimepiride group, there was a significant reduction in intrahepatic lipid content and total body fat mass on H-MRS and DEXA despite a similar decrease in HbA1c [92]
FAQ What is glutathione
In our pursuit of clinical excellence, we're thrilled to introduce you to Zepbound, a groundbreaking GLP-1 drug with FDA approval for weight loss, and share how it seamlessly integrates with our expertise in tummy tucks, breast augmentation, mommy makeovers, and body contouring
Authorship All named authors meet the International Committee of Medical Journal Editors (ICJME) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published
.jpg)
